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Medicinal plants used for wound healing and skin diseases are the key to unlocking
the doors to combating problematic skin diseases as resistance of pathogens to
pharmaceuticals and allopathic management continues to increase. The study aimed
at investigating the antimicrobial efficacies, phenolic content, and cytotoxicity effects
of 11 medicinal plant extracts commonly used for treating skin conditions and wound
healing in traditional medicine within KwaZulu-Natal. Eleven plant species were separated
into different plant parts (bulbs, roots, leaves) and extracted with different solvents. The
extracts were assessed for antimicrobial activity against six Gram-positive and seven
Gram-negative bacterial strains and four fungi commonly associated with skin conditions
using disc diffusion and microdilution techniques. The aqueous methanolic extracts were
screened for phenolic content while cytotoxicity tests were performed on all extracts
using the brine shrimp lethality and tetrazolium–based colorimetric (MTT) assays. Extracts
from Aloe ferox, A. arborescens, and Hypericum aethiopicum were the most active
against almost all of the tested bacterial and fungal strains. All plant species exhibited
some degree of antimicrobial activity. Total phenolic levels, flavonoids and tannins were
also higher for A. ferox, followed by A. arborescens and H. aethiopicum, respectively.
The cytotoxicity results of all plant extracts were in the range of 90–100% survival after
24 h in the brine shrimp assay. Extracts considered lethal would demonstrate >50%
shrimp death. The MTT cytotoxicity test yielded LC50 values of >1mg/mL on all extracts
indicating that they are not cytotoxic. The observed antimicrobial efficacy demonstrated
by some plant species and the general lack of cytotoxic effects on all the tested extracts
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presents some promising and beneficial aspects of these medicinal plant extracts in the
treatment of skin diseases and wound healing. The two Aloe species and H. aethiopicum
were among the best extracts that exhibited consistently good antimicrobial activity and
warrants further investigations and possible isolation of bioactive principles.
Keywords: antimicrobial, cytotoxicity, phenolic compounds, skin diseases, wound healing
INTRODUCTION
South Africa’s rich plant diversity makes it a country where
there is a high demand for medicinal plants with an estimated
70% of its indigenous people consulting traditional healers for
their primary health care needs. The intensive utilization of
natural medicines from the integral components of indigenous
plant parts like leaves, roots, corms, and bulbs necessitates the
protection of many species as their wild populations are declining
due to excessive harvesting for export, trade, and medicinal
use (Hutchings, 1989; Mander, 1997, 1998). This practice is
a common characteristic in developing countries (Farnsworth,
1994; Srivastava et al., 1996). According to Ahn et al. (2001), it is
known that many pathogens are becoming resistant to allopathic
medicines and the need for extensive research and technological
development of safe phytopharmaceuticals from traditionally
used plants may be the solution to reducing the wide range of
diseases. A number of traditionally used plant species have to date
been screened for their bioactivities, withmost of these displaying
promising antimicrobial activity (McGaw et al., 2000; Mathabe
et al., 2006; de Wet et al., 2010). Extensive scientific evidence
for the development of antimicrobial products from plants for
further studies have led to successful patents (Fox, 1999). South
African research, reports effective traditional remedies against
Gram-positive and Gram-negative pathogens and against fungi.
However, although a number of plant species have been identified
for treating burns, rashes, boils, mouth blisters, insect bites, cold
sores, and cracked skin (Raina et al., 2008; Nagori and Solanki,
2011), there is still a paucity of literature on remedies specifically
for the treatment of skin diseases and wounds. Dermatology is
regarded a specialty that has both medical and surgical aspects. It
treats diseases, in the widest sense, and some cosmetic problems
of the skin, scalp, hair, and nails. Boils, sores, and cabuncles
are all consequences of skin diseases and result in wounds in
the skin hence dermatological is often used synonymously with
skin diseases. Pathogenic infection is one of the major challenges
in the wound healing processes and skin diseases. To make
available inexpensive and easy to access skin and wound healing
remedies, an evaluation of medicinal plants used traditionally by
local people for the treatment of such conditions is an essential
priority. Medicinal plants forms the mostly utilized source of
primary healthcare for most of the resource-poor communities
in developing nations including South Africa (WHO, 2002).
The World Health Organization (WHO, 2002), the African
Union Decade of Traditional Medicines (AU, 2005), and the
Convention on Biodiversity (De Souza Dias, 2016) all advocate
for the promotion of traditional medicine through conservation,
sustainable utilization, and the development of medicinal plants
and indigenous knowledge (Heinrich et al., 2004). Part of the
Medicines Control Council of South Africa’s primary concern is
the lack of verifiable results/data by observation or experience,
rather than theory or pure logic data with regard to the measures
of safety, quality, and efficacy of these plant extracts to adequately
protect public safety (Scott et al., 2004). Traditional healers
are valuable in assisting medicinal plant research because of
their experience and expertize in the clinical use of these plants
(Timmermans, 2003).
In this study, 11 South African medicinal plants used
traditionally for treating wounds and skin-related conditions
were evaluated for their potential use in terms of their
antimicrobial activity against bacterial strains routinely
associated with symptoms such as those found in wounds,
boils, and purulent sores, their phenolic content as well as
cytotoxicity effects. These symptoms of infection may include:
increased pain, swelling, redness, or warmth around the affected
area, redness extending from the affected area, drainage of pus
from the area, fever and can result in septicaemia and death.
MATERIALS AND METHODS
Plant Material
Eleven plant species were collected during 2013 from the
Silverglen Plant Conservancy, Chatsworth, Durban, South
Africa, and voucher specimens (Table 1) were identified and
deposited in the Bews Herbarium University of KwaZulu-Natal
(UKZN), Pietermaritzburg. The samples were separated into
bulbs/corms, leaves, and roots before drying in an oven at a
constant temperature of 50◦C (Ncube et al., 2011) for 5 days after
which they were ground into fine powders and stored at room
temperature in airtight glass bottles.
Preparation of Plant Extracts
The ground samples (20 g) were extracted using five solvents
(hexane, chloroform, dichloromethane, acetone, and methanol)
in a sonication bath containing ice for 1 h with 20ml/g
(w/v) of extractant. The crude extracts were filtered under
vacuum through Whatman No. 1 filter paper and the extracts
concentrated in vacuo at 35◦C using a rotary evaporator.
The concentrated extracts were subsequently dried at room
temperature under a stream of cold air and stored at 4◦C till they
were used for the various assay. The percentage yield of extracts
from each extracting solvent was calculated as the ratio of the
mass of the dried extract to the mass of the ground plant sample.
Antibacterial Activity
The extracts (hexane, chloroform, dichloromethane, acetone, and
methanol) from each of the 11 plant species were preliminarily
evaluated for antibacterial activity using the disc–diffusion
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TABLE 1 | Plants used traditionally for treating skin conditions/diseases and healing wounds used in this study.
Plant species/family Plant parts used Voucher
number
Medicinal uses
Aloe arborescens Mill.
Xanthorrhoeaceae
Leaves, Bulbs SG01/UKZN Leaves and bulbs are used for the treatment of gastrointestinal ailments, asthma,
constipation, oesophageal cancer, tuberculosis, colds and fever, HIV/AIDS
stomach ache, burn wounds, abrasions, bruises, and in childbirth (Hutchings
et al., 1996; Crouch et al., 2006; Klos et al., 2009; Van Wyk et al., 2009).
Aloe aristata Haw.
Xanthorrhoeaceae
Leaves SG02/UKZN Leaf juices are used to treat chronic and severe dermatitis, and wounds, burns,
cuts and eczema, sunburn, insect stings, poison ivy skin irritations, abrasions and
numerous dermatological conditions. Sap eases pain and reduces inflammation,
inhibit cell proliferation, and growth of skin and connective tissue (Jia et al., 2008;
Bedini et al., 2009; Van Wyk et al., 2009).
Aloe ferox Mill.
Xanthorrhoeaceae
Leaves SG03/UKZN Leaf gel used for burns, wounds, and various skin conditions like eczema and
ringworm. Arthritis, conjunctivitis, venereal sores, bruises, pimples, blisters,
ringworm, boils (Diederichs et al., 2009; Van Wyk et al., 2009).
Bulbine frutescens (L.) Willd.
Xanthorrhoeaceae
Leaves, stems, roots SG04/UKZN Leaf sap used for burns, rashes, blisters, insect bites, cracked lips, prickly heat
pimples, acne, cold sores, mouth ulcers, cracked skin. Popular for skin and
wound conditions, fever blisters, rashes, eczema, and ringworm and is
antibacterial (Diederichs et al., 2009; Van Wyk et al., 2009).
Bulbine natalensis Baker.
Xanthorrhoeaceae
Leaves, bulbs, roots SG05/UKZN Leaf sap directly applied to skin to treat wounds, sores, burns, rashes, itches,
ringworm, cracked lips and herpes, rheumatism, sunburn, itches, mouth ulcers
(Van Wyk et al., 2009).
Eucomis autumnalis (Mill.)
Chitt. Asparagaceae
Leaves, stem, bulbs SG06/UKZN Bulb used for post-operative recovery, assist in healing fractures, emetics, treat
fever, STI’s, facilitate childbirth. Backache, inflammation, pain, rheumatism
(Diederichs et al., 2009; Van Wyk et al., 2009).
Haworthia limifolia Marloth.
Xanthorrhoeaceae
Leaves, stem, roots SG07/UKZN Leaves treat stomach complaints, sores, superficial burns and sun burn, purify
blood, promotes fertility in women, and cleans the digestive system. Enemas for
internal tumors, sprains, fractures, boils, antischisomal and anthelminthic activity,
antiseptic, anti-inflammatory properties (Diederichs et al., 2009; Van Wyk et al.,
2009; Coopoosamy and Naidoo, 2011a).
Hypericum aethiopicum
Thunb. Hypericaceae
Leaves, stem, roots SG08/UKZN Leaf oil extracts are used in the treatment of wounds and first degree burns,
treats backache, and loin pain as well as fevers (Rood, 1994; Bruneton, 1995;
Hutchings et al., 1996; Van Wyk et al., 2009).
Merwilla plumbea (Lindl.)
Speta Asparagaceae
Leaves, bulbs, roots SG09/UKZN Bulb decoctions used to treat boils, sores, wounds healing, sprains and remove
scar tissue, emetic for cleaning out, and rejuvenating the body. Various skin
ailments, sprains, fractures, infertility, male libido, internal tumors,
anti-inflammatory, antiseptic (Crouch et al., 2006; Diederichs et al., 2009; Van
Wyk et al., 2009).
Tetradenia riparia (Hochst.)
Codd. Lamiaceae
Stem, leaves SG10/UKZN Leaves used for coughs, colds, chest complaints, respiratory problems, diarrhea,
flatulence, nausea, mouth ulcers, stomach ache, diarrhea, influenza, fever,
malaria, swollen legs, headaches (Watt and Breyer-Brandwijk, 1962; Dyson et al.,
1998; Coopoosamy and Naidoo, 2011b).
Zantedeschia aethiopica (L.)
Spreng. Araceae
Stem, bulb/rhizome SG11/UKZN Leaf soothes burns, insect bites, draws wounds, sores and boils; boiled rhizomes
for bronchitis, asthma, heartburn, rheumatism; gargles for mouthwash, Treats
wounds, inflammation, sore, boils, rheumatism, gout, bronchitis, asthma,
heartburn, sore throat (Dyson et al., 1998; Van Wyk et al., 2009).
method (Yu et al., 2003). Twenty plant extracts with zone
inhibitions of ≥10mm were selected from the disc diffusion
assay for further evaluation and their minimum inhibitory
concentrations (MIC) determined using the microdilution
bioassay against six Gram-positive and seven Gram-negative
bacterial strains associated with skin conditions as described
by Eloff (1998) and detailed in Ncube et al. (2011). All
extracts were re-suspended in 70% ethanol for the MIC assay.
Neomycin (Sigma Aldrich, Germany) at a starting concentration
of 0.1µg/mL was used as a positive control against each
bacterium. Water and 70% ethanol were used as negative and
solvent controls respectively. The assay was repeated twice with
two replicates per assay.
Antifungal Activity
Following disc–diffusion preliminary screening, 20 extracts
were selected for further evaluation using the microplate
dilution technique against four fungal strain commonly
associated with skin conditions (Table 3). The MICs for the
extracts were determined using the microdilution bioassay
as described by Eloff (1998) and modified for fungi (Masoko
et al., 2007) as detailed in Ncube et al. (2011). All extracts
were re-suspended in 70% ethanol and Amphotericin B
(Sigma Aldrich, Germany) at a starting concentration
of 0.1µg/mL was used as a positive control against each
fungus. The assay was repeated twice with two replicates per
assay.
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Phenolic Composition
Total Phenolic, Flavonoid, and Proanthocynidin
Content Determination
Dried whole plant samples (1 g) were extracted with 20ml of
50% (v/v) aqueous methanol by sonication on ice for 30 min.
The extracts were then filtered under vacuum throughWhatman
No. 1 filter paper. The amounts of total phenolic compounds
in plant samples were determined using the Folin-Ciocalteu
(Folin C) assay as described by Makkar (1999) with slight
modifications. Fifty microliters of each extract were transferred
into test tubes into which 950µl distilled water were added
followed by 1 N Folin C reagent (500µl) and 2% sodium
carbonate (2.5ml). The test mixtures were incubated for 40min
at room temperature and the absorbance read at 725 nm using
a UV- visible spectrophotometer (Varian Cary 50, Australia)
against a blank consisting of aqueous methanol instead of extract.
Total phenolic concentrations were expressed in mg gallic acid
equivalents (GAE) per g dry weight (DW).
Total flavonoid content was determined following the vanillin
assay (Hagerman, 2002) as detailed by Ncube et al. (2013).
Extracts (50µl), were made up to 1ml with methanol in
test tubes before adding 2.5ml methanolic- HCl (95:5, v/v)
and 2.5ml vanillin reagent (1 g/100 mL glacial acetic acid).
Similar preparations of a blank that contained methanol
instead of plant extracts were made. After 20min at room
temperature, absorbance was read at 500 nm using a UV- visible
spectrophotometer. A catechin standard curve was prepared
from a freshly made 1mg/mL catechin (Sigma-Aldrich) stock
solution in methanol. The flavonoid content was expressed as µg
catechin equivalents (CTE) g DW derived from a standard curve.
The Butanol-HCl assay (Porter et al., 1986), was used to
quantify proanthocynidin content. Three milliliters of butanol-
HCl reagent (95:5, v/v) were added to 500µl of each extract,
followed by 100µl ferric reagent (2% ferric ammonium sulfate
in 2 N HCl). The test combination was mixed by vortexing and
placed in a boiling water bath for 60min. Absorbance was then
read at 550 nm using a UV- visible spectrophotometer against a
blank prepared in a similar way but without heating. Condensed
tannins (%) were calculated as leucocyanidin equivalents (LE;
Porter et al., 1986).
Cytotoxicity Tests
Brine Shrimp Assay
The brine shrimp assay (Meyer et al., 1982) was used to determine
extract toxicity to brine shrimps (Artemia salina). Brine shrimp
eggs (Ocean NutritionTM PET 152) obtained from Northlands
Pets, Durban, South Africa were hatched under light in a 500ml
beaker containing sea water for 36–48 h. The eggs were ready
once swimming brine shrimp nauplii had hatched. Two mg/mL
of each plant extract were two-fold serially diluted into five
concentrations (2, 1, 0.5, 0.25, and 0.125mg/mL). Ten to fifteen
live shrimps were transferred from the hatching beaker to each
test tube using a Pasteur pipette with sea water and topped up to
10ml with sea water. This was done in triplicate for every diluted
plant extract. Each plant extract (100µl) was added to the test
tubes and allowed to stand at room temperature for 24 h. DMSO
and an organophosphate served as negative and positive controls
respectively. For the plant extract to be lethal, shrimp death of
>50% had to be recorded after 24 h.
MTT Colorimetric Assay MTT (3-(4,
5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium
Bromide)
The method described by Mosmann (1983) and McGaw et al.
(2000) was used to determine the cytotoxicity of the crude
extracts. The plant extracts were tested for cytotoxicity against
African green monkey Vero kidney cells obtained from the
Department of Veterinary Tropical Diseases (University of
Pretoria). The cells were maintained in Minimal Essential
Medium (MEM, Whitehead Scientific) supplemented with
0.1% gentamycin (Virbac) and 5% fetal calf serum (Highveld
Biological). Cell suspensions were prepared from confluent
monolayer cultures and plated at a density of 5 × 104 cells
into each well of a sterile 96-well microtitre plate. Plates were
incubated for 24 h at 37◦C in a 5% CO2 incubator until
the cells were in an exponential phase of growth and the
subconfluent cells in the microtitre plate were used in the
cytoxicity assay. Stock solutions of the plant extracts (200µl)
were prepared by serial dilutions in ethanol and prepared in
MEM and added to the cells. The viable cell growth after
120 h incubation with plant extracts was determined using the
tetrazolium-based colorimetric assay (3- (4, 5-dimethylthiazol)-
2, 5-diphenyltetrazolium bromide) (MTT), (Sigma) described
by Mosmann (1983). Untreated cells and a positive control
(Doxorubicin chloride, Pfizer Laboratories) were included. The
amount of MTT reduction was measured immediately by
detecting absorbance using a Chromate 4300 microplate reader
at 540 nm and a reference wavelength of 630 nm. The wells
in column 1, containing medium and MTT but no cells, were
used to standardize the plate reader. The LC50 values were
calculated as the concentration of test compound resulting in
a 50% reduction of absorbance as compared to untreated cells.
The intensity of color was directly proportional to the number of
surviving cells and viable cell growth. Tests were carried out in
quadruplicate and each experiment was repeated three times.
RESULTS AND DISCUSSION
The MIC’s values for antibacterial and antifungal activity are
presented in Tables 2, 3, respectively. Ríos and Recio (2005)
suggested that MIC values are of interest when MICs of 0.1 and
0.01mg/mL for extracts and isolated compounds are recorded.
Fabry et al. (1998) defined active crude extracts as those having
MIC values <8mg/mL. In this study, MIC values of <1mg/mL
were considered to have good activity. Of the different extracts,
chloroform extracts showed the greatest activity for the majority
of the tested extracts. Overall, many of the extracts were effective
across a wide range of both Gram-positive and Gram-negative
bacteria, with Staphylococcus aureus (Gram-positive) and Proteus
mirabilis (Gram-negative) being the most susceptible strains. The
chloroform and DCM extracts of A. ferox and A. arborescens
were the most effective against most of the tested bacterial strains
(Table 2) as well as all the tested fungal strains (Table 3), with
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TABLE 2 | Antibacterial activity (MIC mg/mL) of the tested plant extracts.
Gram-positive Gram-negative
Plant Extract Part M(+) Bs(+) Sp(+) Sa(+) Se(+) Ab (+) Kp(−) Ea(−) Spy(−) Pv(−) Pa(−) Pm(−) Ss(−)
Z. aethiopicum Chloro Leaves 2.50 0.63 2.50 2.50 2.50 2.50 1.25 2.50 2.50 2.50 2.50 0.31 2.50
Meth Leaves 1.25 0.63 2.50 2.50 2.50 2.50 1.25 1.25 2.50 2.50 2.50 0.63 2.50
Chloro Stems 1.25 2.50 2.50 2.50 2.50 2.50 1.25 1.25 2.50 2.50 2.50 0.63 2.50
B. frutescens Chloro Leaves 1.25 0.63 0.63 0.63 2.50 2.50 1.25 1.25 0.63 0.63 0.63 0.63 2.50
Meth Leaves 1.25 2.50 2.50 0.63 2.50 2.50 1.25 1.25 2.50 0.63 2.50 2.50 2.50
Chloro Bulbs 1.25 2.50 1.25 2.50 0.63 0.63 1.25 1.25 2.50 2.50 2.50 0.63 0.63
E. autumnalis DCM Leaves 1.25 2.50 1.25 2.50 2.50 0.63 1.25 1.25 2.50 2.50 2.50 0.63 2.50
Acet Leaves 1.25 2.50 1.25 2.50 0.63 0.63 1.25 1.25 2.50 2.50 2.50 0.63 0.63
Acet Bulbs 1.25 2.50 1.25 2.50 2.50 0.63 1.25 1.25 2.50 2.50 2.50 0.63 2.50
Chloro Bulbs 1.25 2.50 1.25 2.50 2.50 0.63 1.25 1.25 2.50 2.50 2.50 0.63 2.50
Acet Roots 1.25 0.63 1.25 0.63 2.50 2.50 1.25 1.25 0.63 0.63 0.63 2.50 2.50
Chloro Roots 1.25 0.31 1.25 2.50 2.50 2.50 1.25 1.25 0.63 0.63 0.63 0.63 2.50
T. riparia Chloro Stems 1.25 2.50 1.25 2.50 2.50 0.63 1.25 1.25 2.50 2.50 2.50 2.50 2.50
Acet Stems 1.25 2.50 1.25 2.50 2.50 0.63 2.50 1.25 2.50 2.50 2.50 2.50 2.50
Hex Leaves 1.25 0.31 1.25 2.50 2.50 1.25 2.50 1.25 0.63 0.63 0.63 2.50 1.25
Chloro Leaves 2.50 0.63 1.25 0.63 2.50 1.25 0.63 2.50 0.63 2.50 2.50 1.25 1.25
Acet Leaves 0.63 0.63 1.25 0.63 1.25 1.25 0.63 0.63 0.63 2.50 2.50 1.25 1.25
Meth Leaves 2.50 2.50 1.25 0.63 1.25 1.25 2.50 0.63 2.50 2.50 0.63 1.25 1.25
H. aethiopicum Chloro Leaves 0.31 0.31 0.63 0.31 1.25 1.25 0.31 0.63 0.31 2.50 2.50 1.25 1.25
DCM Leaves 0.63 0.63 2.50 0.63 1.25 1.25 0.63 0.63 0.31 2.50 2.50 1.25 1.25
Acet Leaves 0.63 0.63 1.25 0.63 1.25 1.25 0.63 0.63 0.63 2.50 2.50 1.25 1.25
M. plumbea Hex Leaves 0.63 0.63 1.25 0.63 1.25 1.25 2.50 2.50 0.16 0.63 0.63 1.25 1.25
Meth Bulbs 2.50 2.50 1.25 2.50 1.25 1.25 1.25 1.25 0.63 1.25 2.50 1.25 1.25
Chloro Bulbs 1.25 2.50 1.25 0.63 1.25 1.25 1.25 1.25 2.50 1.25 2.50 0.63 1.25
DCM Leaves 2.50 2.50 1.25 0.63 1.25 1.25 1.25 1.25 2.50 1.25 2.50 0.63 1.25
Acet Leaves 1.25 2.50 1.25 2.50 2.50 2.50 1.25 1.25 2.50 1.25 2.50 0.63 1.25
B. natalensis Chloro Bulbs 1.25 0.63 1.25 0.63 0.63 2.50 2.50 1.25 0.63 1.25 2.50 0.63 1.25
Hex Leaves 2.50 0.63 1.25 0.63 2.50 2.50 1.25 1.25 0.63 0.63 0.63 0.63 1.25
A. aristata Acet Leaves 1.25 2.50 2.50 0.63 0.63 2.50 2.50 1.25 2.50 2.50 2.50 0.16 1.25
DCM Leaves 1.25 2.50 1.25 0.63 0.63 2.50 2.50 1.25 2.50 2.50 2.50 0.63 1.25
Hex Leaves 2.50 2.50 1.25 0.63 0.63 2.50 2.50 1.25 1.25 1.25 2.50 0.63 0.63
H. limifolia Hex Leaves 2.50 2.50 2.50 0.63 0.63 2.50 2.50 2.50 0.63 2.50 2.50 0.63 2.50
Chloro Leaves 1.25 1.25 1.25 0.63 0.63 1.25 1.25 1.25 0.63 1.25 1.25 0.63 1.25
A. ferox Chloro Leaves 0.63 0.31 0.31 0.31 0.31 0.63 0.31 0.31 0.31 0.31 0.31 0.31 0.31
A. arborescens DCM Leaves 1.25 0.31 0.63 0.63 0.63 0.63 1.25 0.63 0.31 0.63 0.63 0.63 0.63
Neomycin µg/ml 0.16 0.16 0.16 0.16 0.16 0.08 0.16 0.08 0.16 0.16 0.16 0.16 0.16
Ab, Actinomycetes brasielensis; Bs, Bacillus subtilus; M, Micrococcus spps; Sa, Staphylococcus aureus; Se, Staphylococcus epidermidis; Sp, Streptococcus pneumonia; Spy,
Streptococcus pyogenes; Ea, Enterobacter aerogenes; Kp, Klebsiella pneumonia; Pa, Pseudomonas aeruginosa; Ss, Shigella sonnei; Pm, Proteus mirabilis and Pv, Proteus vulgaris.
Values written in bold are considered very active (<1mg/mL).
A. ferox having MIC values of 0.31 mg/mL against all strains of
bacteria exceptMicrococcus spps. and Actinomycetes brasielensis.
The consistency and broad range activity of these two
extracts against the skin conditions associated microorganisms
demonstrates that the plant species may offer some degree of
efficacy in treating the skin conditions like ringworm, ulcers,
boils, sunburn, blisters, venereal sores, eczema, inflammation,
etc. Traditionally, apart from treating wounds and various
skin conditions, the two Aloe species are reportedly to be
used to treat a number of other ailments such as venereal
sores, bruises, pimples, blisters, ringworm, boils, gastrointestinal
ailments, asthma, constipation, oesophageal cancer, tuberculosis,
colds and fever, HIV/AIDS opportunistic infections, stomach
ache, and in childbirth (Hutchings et al., 1996; Crouch et al., 2006;
Diederichs et al., 2009; Klos et al., 2009; Van Wyk et al., 2009).
Aloe species contain many interesting secondary metabolites
belonging to different classes of compounds and these are
responsible for their healing properties. These species contain
many types of compounds, such as alkaloids, anthraquinones,
pre-anthraquinones, anthrones, bianthraquinoids, chromones,
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TABLE 3 | Antifungal activity (MIC mg/mL) of the selected plant extracts.
Plant Extract Part Tr Tm Ca Ct
Z. aethiopicum Meth Leaves 0.63 1.25 1.25 0.63
Chloro Stems 0.63 0.63 1.25 1.25
Acet Stems 1.25 0.63 1.25 1.25
E. autumnalis Acet Leaves 1.25 1.25 1.25 0.63
Chloro Bulbs 1.25 1.25 1.25 0.63
T. riparia Chloro Stems 0.31 0.63 1.25 1.25
Acet Stems 1.25 0.63 0.63 1.25
Meth Leaves 0.63 0.63 1.25 1.25
M. plumbea Chloro Bulbs 0.63 0.63 0.31 1.25
Acet Bulbs 1.25 0.63 0.63 0.63
Hex Leaves 1.25 0.63 1.25 0.63
Chloro Leaves 0.63 0.63 1.25 0.63
Acet Roots 1.25 0.63 1.25 0.63
Meth Roots 1.25 0.63 1.25 0.63
B. natalensis Chloro Leaves 1.25 0.31 0.63 0.63
B. frutescens Chloro Leaves 1.25 0.63 0.63 0.63
A. aristata Acet Leaves 0.63 0.63 0.63 0.63
DCM Leaves 0.63 0.63 0.63 0.63
Hex Leaves 0.31 1.25 0.63 0.63
H. limifolia Hex Leaves 0.63 0.63 0.63 0.63
Chloro Leaves 0.63 0.63 0.63 0.63
A. ferox Chloro Leaves 0.63 0.31 0.63 0.63
DCM Leaves 0.63 0.31 0.63 0.63
H. aethiopicum Chloro Leaves 0.63 0.63 0.63 0.63
A. arborescens DCM Leaves 0.63 0.63 0.63 0.63
Amphotericin B µg/ml 0.93 0.93 0.93 0.93
Tr, Trichophyton rubrum; Tm, Trichophyton mentagrophytes; Ca, Candida albicans; Ct,
Candida tropicalis. Values written in bold are considered very active (<1 mg/mL).
flavonoids, coumarins, and pyrenes. The numerous bioactive
compounds isolated from Aloe species include among others,
aloe-emodin, coniine, aloesaponol I-IV, aloin A/B, (barbaloin),
aloinoside A/B, feroxin A/B, aloesone, lupeol (Waller, 1978;
Dagne et al., 2000; Girelli et al., 2001). In addition, the other
extracts demonstrated good activity on at least two of the tested
microorganisms. Extracts, in addition to chloroform for the
three Aloe species showed good activity for most of the tested
microorganisms; hexane and chloroform extracts of Hypericum
limifolia and the DCM extract of H. aethiopicum (Table 2)
exhibited good activity against all the fungal strains tested.
The number of efficacious drugs available clinically for the
treatment of fungal infections is very limited and antimicrobial
resistance is one of the major challenges in the treatment of
fungal infections (Ruhnke et al., 1994). Against this background,
the good bioactivity displayed by these plant extracts provide
new alternatives to the treatment of fungal infections and thus
an opportunity to circumvent the often poorly efficient but
expensive fungal treatments.
The Gram-positive bacterium S. epidermidis is one of the
common causes of skin infections such as pimples, boils,
carbuncles, and abscesses (Singer and Talan, 2014). Resistant
strains such as S. aureus have become a global challenge and
TABLE 4 | Brine Shrimp Lethality and Cytotoxicity effects (MTT assay) of
the different plant extracts used in this study.
Plants extract LC50 (mg/mL) Brine LC50 (mg/mL)
shrimp lethality MTT assay
A. arborescens leaves >2 >1
A. aristata leaves >2 >1
A. ferox leaves 1.93 >1
B. frutescens leaves >2 >1
B. frutescens bulbs >2 >1
B. natalensis leaves >2 >1
B. natalensis bulbs >2 >1
E. autumnalis leaves >2 >1
E. autumnalis bulbs >2 >1
E. autumnalis roots >2 >1
H. limifolia leaves >2 >1
H. aethiopica leaves >2 >1
M. plumbea leaves >2 >1
M. plumbea bulbs >2 >1
M. plumbea roots >2 >1
T. riparia leaves >2 >1
T. riparia stems >2 >1
Z. aethiopicum leaves >2 >1
Z. aethiopicum stems >2 >1
DMSO >2
Organophosphate – Doxorubicin LC50 (uM) 4.654 ± 0.971
S. epidermidis is likely to be added onto the list. Hypericum
aethiopicum (Unsukumbili) is reported in a survey conducted on
plants among communities in the Ungoye Forest in Northern
KwaZulu-Natal, South Africa as the most used plant of choice
used for healing sores and wounds (Mthethwa and De Wet,
2011). The effective activity shown by this species together
with the Aloe species against such pathogenic strains as K.
pneumoniae, S. epidermidis, S. aureus, and all four tested fungi
may provide significant information on their use against the
skin diseases caused by these pathogens. Various studies in the
recent years have evaluated the use of medicinal plants in skin
conditions and wound healing assays. A study on the stem bark
ofDrypetes klainei, amedicinal plant used for skin conditions and
injuries, reported good wound healing properties and treatment
of burns (Brusotti et al., 2015). In a comprehensive review of
African medicinal plants, Agyare et al. (2016) noted that more
than 61 plants belonging to 36 families have been evaluated for
wound healing properties in varying models. Characterization
and isolation of the bioactive compounds remains one of the
main areas to be explored in order to exploit the full benefits of
the botanical extracts.
Phytochemical screening of natural products underpins the
development of cosmetic and anti-aging products. Phenolic
compounds, particularly tannins, and flavonoids are known
to enhance rapid skin regeneration and antimicrobial effects.
Although the bioactivity of the secondary metabolites, including
phenolic compounds, is a function of both quality and quantity
as well as interaction of these metabolites, their respective
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TABLE 5 | The total phenolic, flavonoid, and proanthocyanidin levels of the screened medicinal plants.
Plant species Plant part Total phenolics (mg GAE/ g DW) Flavonoid content (mg CTE/g DW) Proanthocyanidin content (µg LCE/g DW)
A. arborescens Leaves 4.69 ± 0.07 3.41 ± 0.30 1.80 ± 0.02a
A. aristata leaves 4.53 ± 0.09 3.43 ± 0.22 3.51 ± 0.83
A. ferox leaves 4.64 ± 0.10 5.28 ± 0.80 5.28 ± 0.25
B. frutescens Leaves 0.29 ± 0.01 0.66 ± 0.11 0.34 ± 0.04
Bulbs 0.70 ± 0.03 0.64 ± 0.03 0.37 ± 0.08
B. natalensis Leaves 0.22 ± 0.04 0.23 ± 0.04 0.28 ± 0.06
Bulbs 1.19 ± 0.11 1.06 ± 0.08 1.89 ± 0.07
E. autumnalis Leaves 1.61 ± 0.09 1.34 ± 0.03 0.65 ± 0.11
Bulbs 0.15 ± 0.06 0.14 ± 0.03 0.19 ± 0.01
Roots 0.53 ± 0.02 1.21 ± 0.01 0.90 ± 0.05
H. limifolia Leaves 4.46 ± 0.10 3.11 ± 0.84 3.04 ± 0.25
H. aethiopicum Leaves 3.35 ± 0.04 4.56 ± 0.30 9.85 ± 0.20
M. plumbea Leaves 0.80 ± 0.06 1.01 ± 0.04 0.45 ± 0.01
Bulbs 0.59 ± 0.02 0.45 ± 0.07 2.04 ± 1.75
Roots 0.05 ± 0.02 0.78 ± 0.13 0.37 ± 0.08
T. riparia Leaves 1.39 ± 0.10 0.89 ± 0.04 0.43 ± 0.05
Stems 0.56 ± 0.09 0.27 ± 0.05 0.09 ± 0.02
Z. aethiopicum Leaves 0.56 ± 0.03 2.13 ± 0.04 0.61 ± 0.02
Stems 0.16 ± 0.01 0.63 ± 0.06 0.24 ± 0.00
aEach value in the table represent mean values ± standard error (n = 3).
quantities in an extract sometimes gives a correlation with
activity. In skin burns and wound healing processes, phenolic-
protein complexes form a film that prevents dehydration and
creates a physical barrier to damaged tissue thereby preventing
microbial infection and chemical damage (Luseba et al., 2007). It
is through the same mechanism (phenolic-protein complexing)
that these group of compounds are thought to exert their
antimicrobial effects. Total phenolic concentrations, flavonoid
concentration, and proanthocyanidin content of the 11 plant
species are represented in Table 5. The concentration of total
phenolics in the investigated plant samples ranged from 0.05
to 4.69 mg/g DW. The highest concentrations of total phenolic
compounds were found in the leaves of the three Aloe
species (A. arborescens, A. aristata, and A. ferox) followed by
H. limifolia and H. aethiopicum. Coincidentally, the extracts
from these five species also demonstrated good antimicrobial
activity against a number of tested microorganisms. Although,
it is insufficient to draw solid conclusions from just one
group of compounds tested in this study considering the
multitude of compounds produced by plants, the correlation
between the trend in the amount of phenolic compounds
and antimicrobial effects, it is tempting to speculate on the
involvement of these compounds. Phenolic compounds in
plants are purported to serve defense roles against invading
pathogens (Dey and Harborne, 1989; Treutter, 2001) and
important pharmacological activities such as antioxidants,
anticarcinogenic, antibacterial, and anti-inflammatory effects
have been recorded (Sharma et al., 1994; Bruneton, 1995; Kuda
et al., 2005).
An almost similar trend to that of total phenolics
were observed for flavonoids and condensed tannins
(proanthocyanidins). Flavonoids are known for direct
antibacterial properties, synergistic activity with antibiotics
and the ability to suppress bacterial virulence; in addition to
having anti-carcinogenic properties (Tapas et al., 2008). Tannins
are known for antibacterial, anti-parasitic, anti-inflammatory,
and anti-ulcer properties. The proanthocyanidin content
ranged from 0.09 to 9.85µg/g DW with the highest content in
H. aethiopicum, followed by A. ferox, A. aristata, H. limifolia,
B. natalensis, and A. arborescens, respectively. Tannins are
reported to be the key candidates in the phenolic-protein
complexes. The hydroxyl group in phenolic compounds is an
excellent hydrogen donor that forms strong hydrogen bonds
with protein carboxyl groups. Apart from wound healing,
the phenolic-protein properties could exert the antimicrobial
and enzyme inhibitory properties by forming hydrophobic
interactions with the protein regions of the bacterial cell wall
(Ncube and Van Staden, 2015).
In addition to evaluating the plant extracts for
pharmacological properties, it is as important to ascertain
the safety of medicinal plant extracts for human use. Cytotoxicity
assays are some of the important tools for this purpose as they
shed more light on the potential toxic or mutagenic effects of
plant extracts. Toxicity effects of most medicinal plant extracts
are not well documented largely because of the widely held belief
that traditional medicinal plants are safe (Elgorashi et al., 2003).
An evaluation of the toxicity and cytotoxicity are an important
part of ethnopharmacological validations (Van Dyk et al., 2009)
and the severity of toxicity of extracts are often related to
concentration, exposure time, and physiological parameters
(Meyer et al., 1982). The brine shrimp assay determines the
relationship between brine shrimp lethality and cytotoxicity
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and a positive correlation exists between brine shrimp lethality
and cytotoxicity (Ayo et al., 2007). The MTT assay on the other
hand evaluates the survival and proliferation of mammalian
cells upon exposure to the extract(s). The results of the plant
extracts tested in this study using the brine shrimp lethality
assay (Table 4) indicated lack of cytotoxicity after 24 h. For an
extract to be considered lethal it must demonstrate more than
50% shrimp death. The MTT assay further substantiated these
results with reported LC50 values of >1mg/mL on all extracts
(Table 4). An LC50 value of <0.5mg/mL for an extract would be
of cytotoxic concern in this assay while that of below 0.1 mg/mL
is considered highly cytotoxic. The results of the cytotoxicity
assay on the tested extracts show safe levels, however, further
mutagenic and toxicological tests with different mechanisms of
action and targets would be necessary to ascertain the complete
safety of these plant extracts.
CONCLUSIONS
The phytotherapeutic potential of the tested medicinal plants
against skin diseases is demonstrated in most of these extracts.
However, the potential for novel leads are still to be revealed
through isolation and analyses of individual extracts. The lack
of evidence for cytotoxicity in this study asserts to the use of
these plants for wound healing and treatment of skin diseases like
eczema, ringworm, sores, boils, pimples, and infected wounds.
Further pharmacological assays on wound healing would thus
be necessary to help confirm and ascertain the efficacious
capacity of these plants. Further research aimed at identifying
the compounds responsible for the observed activity would have
important relevance to the therapeutic use for skin infections
and wound healing. The results of these analyses are promising
evidence for further comparisons with isolates in future in-vivo
and in-vitro wound healing models.
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